特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
934732

ゲノム編集の世界市場:技術別、用途別、ソース別、エンドユーザー別、地域別の予測と機会

Global Genome Editing Market By Technique, By Applications, By Source, By End-User, By Region, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 113 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

ゲノム編集の世界市場:技術別、用途別、ソース別、エンドユーザー別、地域別の予測と機会
出版日: 2020年05月01日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

ゲノム編集は、人工ヌクレアーゼを使って特定の場所でゲノムを切断することにより細胞や生物のDNAに変更を加える技術であり、合成生物学、細胞株の改変、疾病治療、農業バイオテクノロジーなどさまざまな分野で応用されています。遺伝性疾患、慢性疾患、感染性疾患の患者数増加、幹細胞研究に対して各国政府が投じる資金の増加、新興国のバイオテクノロジー企業や製薬会社の台頭といった要因に促され、市場は着実に成長を続ける見通しです。

当レポートは、世界のゲノム編集市場を調査したもので、各地域市場の展望、市場の力学と動向、競合状況と主要企業のプロファイルなどの情報に加え、戦略的提言も示しています。

目次

第1章 製品の概要

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 世界市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 技術別(CRISPR、ジンクフィンガーヌクレアーゼ、TALEN、制限酵素、その他)
    • 用途別(合成生物学、細胞株と生命体の改変、治療目的でのゲノム編集、その他)
    • ソース別(動物、植物、微生物、ヒト)
    • エンドユーザー別(製薬会社とバイオテクノロジー企業、臨床研究機関、研究機関)
    • 企業別(2019年)
    • 地域別
  • 市場魅力指数

第5章 アジア太平洋市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 技術別
    • 用途別
    • ソース別
    • 国別
  • 市場魅力指数
  • アジア太平洋:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • シンガポール
    • オーストラリア

第6章 欧州市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 技術別
    • 用途別
    • ソース別
    • 国別
  • 市場魅力指数
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア

第7章 北米市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 技術別
    • 用途別
    • ソース別
    • 国別
  • 市場魅力指数
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 南米市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 技術別
    • 用途別
    • ソース別
    • 国別
  • 市場魅力指数
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第9章 中東・アフリカ市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 技術別
    • 用途別
    • ソース別
    • 国別
  • 市場魅力指数
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • UAE

第10章 市場の力学

  • 促進促進要因
  • 課題

第11章 市場の動向

第12章 競合情勢

  • 競合情勢の展望
  • 主要企業のプロファイル
    • Thermofisher Scientific
    • STEMCELL Technologies
    • CRISPR Therapeutics
    • Pfizer
    • Bayer Crop Science
    • Editas Medicine
    • Intellia Therapeutics
    • Cellectis
    • Sangamo Therapeutics
    • Origene Technologies
    • Merck
    • New England Biolabs
    • Lonza Group Ltd.
    • Integrated DNA Technologies
    • Horizon Discovery Group Plc
    • Genscript
    • Transposagen Biopharmaceutical
    • Inari Agriculture
    • Inscripta
    • Beam therapeutics

第13章 戦略的提言

第14章 免責事項

目次
Product Code: 4542

Global genome editing market is expected to grow at a brisk rate during the forecast period owing to growing number of research activities for treatment of various chronic diseases using this technology. Further, increased government funding for genomics technology around the globe, growing preference for personalized medicine and increase in R&D expenditure are fueling the market growth of genome editing.

Genome editing is a way of making specific changes to the DNA of a cell or organism. It could be used to edit the genome of any organism. It uses a type of enzyme called an 'engineered nuclease' which cuts the genome in a specific place. After cutting the DNA in a specific place, the cell naturally repairs the cut. It finds application in large number of areas, such as mutation, therapeutics, and agriculture biotechnology. Moreover, rise in the number of chronic and infectious diseases is likely to fuel the market for genome editing in the coming years.

The global genome editing market is segmented based on technique, applications, source, end-user and region. Based on applications, the market is segmented into synthetic biology, engineering cell line & organisms, therapeutic genome editing and others. Among them, the cell line engineering is expected to witness the highest growth rate in the coming years due to increase in the number of people suffering with genetic disorders and rising government funding for stem cell research.

Based on end-user, the global genome editing market is segmented into pharmaceutical & biotechnology companies, clinical research organization and research institutes. Pharmaceutical & biotechnology companies contribute to the largest share of revenue generation for global genome editing market. Growing establishments of biotech and pharma companies in emerging economies and growing usage of gene editing technique in research activities undertaken by them to manufacture and develop drugs for rare diseases anticipated to fuel the market across the globe.

Major players operating in the global genome editing market include Thermofisher Scientific, STEMCELL Technologies, CRISPR Therapeutics, Pfizer, Bayer Crop Science, Editas Medicine, Intellia Therapeutics , Cellectis, Sangamo Therapeutics , Origene Technologies, Merck, New England Biolabs, Lonza Group Ltd., Integrated DNA Technologies, Horizon Discovery Group Plc, Genscript, Transposagen Biopharmaceutical, Inari Agriculture, Inscripta, Beam therapeutics and others. Growing number of researches and developments in healthcare industry are expected to drive genome editing market until 2025.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global genome editing market.
  • To classify and forecast global genome editing market based on technique, applications, source, end-user, company and regional distribution.
  • To identify drivers and challenges for global genome editing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global genome editing market.
  • To conduct pricing analysis for global genome editing market.
  • To identify and analyze the profile of leading players operating in global genome editing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global genome editing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Genome editing companies, end users and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to genome editing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global genome editing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technique:

CRISPR

Zinc Finger Nucleases

TALENs

Restriction Enzymes

Others

  • Market, By Applications:

Synthetic Biology

Engineering Cell Line & Organisms

Therapeutic Genome Editing

Others

  • Market, By Source:

Animal

Plant

Microbes

Human

  • Market, By End-User:

Pharmaceutical & Biotechnology Companies

Clinical Research Organization

Research Institutes

  • Market, By Region:

Asia-Pacific

Europe

North America

South America

Middle East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global genome editing market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Genome Editing Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value & Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Technique (CRISPR, Zinc Finger Nucleases, TALENs, Restriction enzymes, Others)
    • 4.2.2. By Applications (Synthetic Biology, Engineering cell line & organisms, Therapeutic Genome Editing, Others)
    • 4.2.3. By Source (Animal, Plant, Microbes, Human)
    • 4.2.4. By End-User (Pharmaceutical & Biotechnology Companies, Clinical Research Organization, Research Institutes)
    • 4.2.5. By Company (2019)
    • 4.2.6. By Region
  • 4.3. Market Attractiveness Index

5. Asia-Pacific Genome Editing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique
    • 5.2.2. By Application
    • 5.2.3. By Source
    • 5.2.4. By Country
  • 5.3. Market Attractiveness Index
  • 5.4. Asia-Pacific: Country Analysis
    • 5.4.1. China Genome Editing Market Outlook
      • 5.4.1.1. Market Size & Forecast
        • 5.4.1.1.1. By Value
      • 5.4.1.2. Market Share & Forecast
        • 5.4.1.2.1. By Technique
        • 5.4.1.2.2. By Source
        • 5.4.1.2.3. By Application
    • 5.4.2. India Genome Editing Market Outlook
      • 5.4.2.1. Market Size & Forecast
        • 5.4.2.1.1. By Value
      • 5.4.2.2. Market Share & Forecast
        • 5.4.2.2.1. By Technique
        • 5.4.2.2.2. By Source
        • 5.4.2.2.3. By Application
    • 5.4.3. Japan Genome Editing Market Outlook
      • 5.4.3.1. Market Size & Forecast
        • 5.4.3.1.1. By Value
      • 5.4.3.2. Market Share & Forecast
        • 5.4.3.2.1. By Technique
        • 5.4.3.2.2. By Source
        • 5.4.3.2.3. By Application
    • 5.4.4. South Korea Genome Editing Market Outlook
      • 5.4.4.1. Market Size & Forecast
        • 5.4.4.1.1. By Value
      • 5.4.4.2. Market Share & Forecast
        • 5.4.4.2.1. By Technique
        • 5.4.4.2.2. By Source
        • 5.4.4.2.3. By Application
    • 5.4.5. Singapore Genome Editing Market Outlook
      • 5.4.5.1. Market Size & Forecast
        • 5.4.5.1.1. By Value
      • 5.4.5.2. Market Share & Forecast
        • 5.4.5.2.1. By Technique
        • 5.4.5.2.2. By Source
        • 5.4.5.2.3. By Application
    • 5.4.6. Australia Genome Editing Market Outlook
      • 5.4.6.1. Market Size & Forecast
        • 5.4.6.1.1. By Value
      • 5.4.6.2. Market Share & Forecast
        • 5.4.6.2.1. By Technique
        • 5.4.6.2.2. By Source
        • 5.4.6.2.3. By Application

6. Europe Genome Editing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Application
    • 6.2.3. By Source
    • 6.2.4. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Europe: Country Analysis
    • 6.4.1. France Genome Editing Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Technique
        • 6.4.1.2.2. By Source
        • 6.4.1.2.3. By Application
    • 6.4.2. Germany Genome Editing Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Technique
        • 6.4.2.2.2. By Source
        • 6.4.2.2.3. By Application
    • 6.4.3. United Kingdom Genome Editing Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Technique
        • 6.4.3.2.2. By Source
        • 6.4.3.2.3. By Application
    • 6.4.4. Italy Genome Editing Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Technique
        • 6.4.4.2.2. By Source
        • 6.4.4.2.3. By Application

7. North America Genome Editing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Application
    • 7.2.3. By Source
    • 7.2.4. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. North America: Country Analysis
    • 7.4.1. United States Genome Editing Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Technique
        • 7.4.1.2.2. By Source
        • 7.4.1.2.3. By Application
    • 7.4.2. Mexico Genome Editing Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Technique
        • 7.4.2.2.2. By Source
        • 7.4.2.2.3. By Application
    • 7.4.3. Canada Genome Editing Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Technique
        • 7.4.3.2.2. By Source
        • 7.4.3.2.3. By Application

8. South America Genome Editing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Application
    • 8.2.3. By Source
    • 8.2.4. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. South America: Country Analysis
    • 8.4.1. Brazil Genome Editing Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Technique
        • 8.4.1.2.2. By Source
        • 8.4.1.2.3. By Application
    • 8.4.2. Argentina Genome Editing Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Technique
        • 8.4.2.2.2. By Source
        • 8.4.2.2.3. By Application
    • 8.4.3. Colombia Genome Editing Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Technique
        • 8.4.3.2.2. By Source
        • 8.4.3.2.3. By Application

9. Middle East and Africa Genome Editing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Application
    • 9.2.3. By Source
    • 9.2.4. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. MEA: Country Analysis
    • 9.4.1. South Africa Genome Editing Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Technique
        • 9.4.1.2.2. By Source
        • 9.4.1.2.3. By Application
    • 9.4.2. Saudi Arabia Genome Editing Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Technique
        • 9.4.2.2.2. By Source
        • 9.4.2.2.3. By Application
    • 9.4.3. UAE Genome Editing Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Technique
        • 9.4.3.2.2. By Source
        • 9.4.3.2.3. By Application

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape

  • 12.1. Competition Outlook
  • 12.2. Players Profiled (Leading Companies)
    • 12.2.1. Thermofisher Scientific
    • 12.2.2. STEMCELL Technologies
    • 12.2.3. CRISPR Therapeutics
    • 12.2.4. Pfizer
    • 12.2.5. Bayer Crop Science
    • 12.2.6. Editas Medicine
    • 12.2.7. Intellia Therapeutics
    • 12.2.8. Cellectis
    • 12.2.9. Sangamo Therapeutics
    • 12.2.10. Origene Technologies
    • 12.2.11. Merck
    • 12.2.12. New England Biolabs
    • 12.2.13. Lonza Group Ltd.
    • 12.2.14. Integrated DNA Technologies
    • 12.2.15. Horizon Discovery Group Plc
    • 12.2.16. Genscript
    • 12.2.17. Transposagen Biopharmaceutical
    • 12.2.18. Inari Agriculture
    • 12.2.19. Inscripta
    • 12.2.20. Beam therapeutics

13. Strategic Recommendations

14. About Us & Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.